一项关于数学瘤学的文献计量研究:跨学科性,国际性,协作性和趋势主题
Kira Pugh1, Linnéa Gyllingberg2, Stanislav Stratiev3
1Department of Information Technology, Uppsala University, Uppsala, Sweden. kira.pugh@it.uu.se.
Bulletin of mathematical biology
|November 3, 2025
概括
数学瘤学是一个跨学科领域,自20世纪60年代以来,它已经发生了显著的发展. 这项研究显示了合作的增加,全球范围和各种主题,有利于数学和生命科学.
科学领域:
- 在数学科学和癌症研究交叉的跨学科研究.
- 这是一个充满活力的领域,需要适应技术和医学进步.
背景情况:
- 定义数学瘤学的范围对于资金,教育和社区组织至关重要.
- 图书计量分析提供了一种定量方法,以了解该领域的演变.
研究的目的:
- 进行数学瘤学的文献分析,以确定其范围和演变.
- 将数学瘤学与数学生物学进行比较,并在科学科学框架内定位研究结果.
主要方法:
- 使用文章元数据和引用流的图书统计分析.
- 与数学生物学更广泛的领域进行比较.
- 在理论科学框架内定位发现.
主要成果:
- 自20世纪60年代以来,数学瘤学已经显著发展.
- 有证据表明,越来越多的跨学科互动,地理扩张,更大的研究团队和主题多样性.
- 这些发现有助于讨论大数据和机器学习时代有价值的模型.
结论:
- 国际合作网络对于领域的包容性和增长至关重要.
- 数学瘤学为数学和生命科学提供了互惠的好处.
- 定量证据支持数学瘤学的动态和不断扩展的性质.
相关概念视频
Cancer Survival Analysis
639
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
639
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Genomics
39.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.6K
Actuarial Approach
283
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
283


